The main objective of the WhiteBox EEG project is to develop and commercialise the world`s first scalable, multipurpose, high-throughput, Big Data electroencephalograph (EEG) Platform, that enables doctors, researchers and other EEG practitioners to record and analyse larger sets of EEG data in much shorter timeframes and with considerably lower costs. Such an innovative combination of software and hardware is crucial in order to be able to achieve a wider deployment of EEG technology that is much needed for early detection, diagnosis and treating of a wide array of neurodegenerative diseases.
Hence, the aim of the WhiteBox EEG project is to deploy on a large scale the push-button EEG medical device for early detection of Alzheimer’s dementia which is – due to an ageing population - becoming a growing social and economic burden in EU and beyond. Early detection of Alzheimer’s disease is crucial both for a more effective treatment as well as for managing its rising economic and social impacts. However, Alzheimer Dementia (AD) is one of the most underdiagnosed and undertreated diseases in the world.
With the increased recording capacity of 10+ subjects simultaneously, up to 10 times faster recording output and up to 40% in cost savings compared to the existing EEG recording solutions, our innovative solution will disrupt the market for EEG research and medical diagnostics, EEG equipment and recording platforms and applied neuroscience.
In addition, our scalable EEG recording and analysis solution is also a response to an increased need of experts and clinicians to obtain large standardised databases of brain activity for clinical trials, clinical validation of biomarkers for neurodegenerative diseases and big data and machine learning approaches in brain research.
The high-throughput capabilities and the scalability of the WhiteBox platform provide an answer to a lack of larger databases of standardised and consistent EEG recordings that enable Big Data approaches, which are crucial for the clinical validation of biomarkers.
Our disruptive innovation not only makes the existing EEG recording and analysis faster and cheaper but through its scalability also represents a big opportunity to bring the benefits of EEG brain-imaging technology to new areas of use ranging from medical & research field (such as EEG based predictive disease diagnostics, personalised medicine, big data EEG analysis) to the emerging field of applied neuroscience (such as NeuroEducation, Neuromarketing/Consumer Neuroscience, Neuro-HR and Change Management, User Centred Neurodesign and EEG performance optimization in Professional Sports).
